{"disease":{"id":"skin-enhancement","name":"skin enhancement"},"drugs":{"marketed":[{"drug_id":"trioxsalen","indication_name":"Skin Pigmentation Enhancement","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Trisoralen","generic_name":"TRIOXSALEN","company_name":"","drug_phase":"marketed","molecular_target":"Adenosine receptor A2a","drug_class":"Psoralen","quality_score":10,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04206293","title":"A Study to Evaluate The Impact on Skin Quality Attributes by Juvederm® Volite Injection on Healthy Volunteers","phase":"NA","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"Allergan","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}